Vaxgen (Anthrax Vaccine Assets and Technology)
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Anthrax vaccine program and related assets and technology. The portfolio includes all assets and rights related to a recombinant protective antigen (rPA) anthrax vaccine product.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Acquirer
Primary Office
- 349 Oyster Point Boulevard
- Suite 10
- South San Francisco, CA 94080
- United States
Vaxgen (Anthrax Vaccine Assets and Technology) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Vaxgen (Anthrax Vaccine Assets and Technology)‘s full profile, request access.
Request full access to PitchBookVaxgen (Anthrax Vaccine Assets and Technology) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Vaxgen (Anthrax Vaccine Assets and Technology)‘s full profile, request access.
Request full access to PitchBook